What does Galmed Pharmaceuticals Ltd. do?

Jun 22 2025 06:52 PM IST
share
Share Via
Galmed Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing therapies for liver diseases, particularly Non-alcoholic Steatohepatitis (NASH), with its main product being Arachmol. As of March 2025, it has a market cap of USD 3.78 million and reported a net profit of -1 million.
Overview:
Galmed Pharmaceuticals Ltd. is an Israeli-based clinical-stage biopharmaceutical company focused on developing therapies for treating liver diseases, specifically targeting Non-alcoholic Steatohepatitis (NASH) with its main product, Arachmol. Financial Snapshot: Most recent Net Profit: -1 Million (Quarterly Results - Mar 2025) Market-cap: USD 3.78 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.94 Return on Equity: -36.74% Price to Book: 0.22 Contact Details: Address: 16 Ze'ev Tyomkin St. (4Th Fl.), TEL AVIV-YAFO None: 6578317 Tel: 972 3 6938448 Fax: 972 3 6938447 Website: http://www.galmedpharma.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Galmed Pharmaceuticals Ltd. overvalued or undervalued?
Jun 25 2025 09:08 AM IST
share
Share Via
How big is Galmed Pharmaceuticals Ltd.?
Jun 22 2025 06:07 PM IST
share
Share Via